Atomic AI

Atomic AI

San Francisco, United States· Est. 2021

At Atomic AI, we are harnessing the cutting-edge fusion of machine learning and structural biology to unlock the next generation of RNA-centric medicines, from RNA-targeted small molecules to RNA-based therapeutics. Our foundation model ATOM-1 allows for the world’s most precise predictions of the three-dimensional structure of RNA and is opening up an unprecedented swath of previously inaccessible targets.

Private Company

Total funding raised: $42M

About

At Atomic AI, we are harnessing the cutting-edge fusion of machine learning and structural biology to unlock the next generation of RNA-centric medicines, from RNA-targeted small molecules to RNA-based therapeutics. Our foundation model ATOM-1 allows for the world’s most precise predictions of the three-dimensional structure of RNA and is opening up an unprecedented swath of previously inaccessible targets.

AI / Machine Learning

Funding History

2
Total raised:$42M
Series A$35MJan 15, 2023
Seed$7MJan 15, 2022